HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 1.58
Day range
kr 1.57 - kr 1.62
Year range
kr 0.98 - kr 6.19
Market cap
615.13M SEK
Avg Volume
2.06M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.57M | 87.28% |
Operating expense | 78.24M | -14.59% |
Net income | -65.17M | 21.88% |
Net profit margin | -351.02 | 58.29% |
Earnings per share | — | — |
EBITDA | -60.91M | 25.54% |
Effective tax rate | -1.85% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 82.26M | -53.93% |
Total assets | 134.84M | -44.78% |
Total liabilities | 193.73M | 2.01% |
Total equity | -58.89M | — |
Shares outstanding | 272.71M | — |
Price to book | -7.20 | — |
Return on assets | -88.89% | — |
Return on capital | -125.24% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -65.17M | 21.88% |
Cash from operations | -60.06M | 15.99% |
Cash from investing | — | — |
Cash from financing | -5.34M | -159.13% |
Net change in cash | -65.66M | 8.14% |
Free cash flow | -42.92M | 7.20% |
About
CEO
Founded
2000
Website
Employees
75
